Turning hard science into premium health ventures.
We discover, build and scale evidence-backed consumer brands—under one roof.

Driven by Evidence.
Delivering Real Impact.
Our principles guide every venture we launch.
Evidence-First
Premium by Design
Radical Transparency
Our Venture Portfolio
People Who Bridge Science & Business
Two founders combine 20 + years of nutrition science with world class commercial execution to turn evidence into premium health brands.

Dr Graeme Smith
PhD, R. Nutritionist
Co-Founder
With two decades of leadership across personalised-nutrition R&D, product strategy and venture creation, Graeme is a science-driven executive who transforms breakthrough research into premium consumer offerings. His career spans NEOM, Swisse Wellness, Prenetics and H&H Group, where he launched data-guided supplement lines and opened new APAC markets, underpinned by a PhD in Nutritional Biochemistry and patents in macronutrient sensitivity and exercise genotyping. Passionate about evidence-led innovation and high-performance teams, Graeme blends rigorous scientific insight with commercial acumen—publishing in tier-one journals, advising start-ups to multinationals, and building cross-functional ecosystems that deliver measurable impact and sustainable growth.

Moses Ceraman
MBA, FCG, FGIA
Co-Founder
With over three decades of leadership experience across business strategy, innovation, portfolio management, consulting, and finance, Moses is a seasoned business executive committed to driving ambitious growth and transformational outcomes. His extensive FMCG background includes launching new brands, establishing operations in new markets, and leading global systems rollouts, with a career shaped by globally renowned organizations such as EY, Dilmah Teas, Mars Inc., and Swisse Wellness.Passionate about building innovation-led cultures and high-performing ecosystems, Moses brings a powerful blend of strategic agility, commercial acumen, and strong stakeholder engagement to consistently deliver impactful results and foster sustainable success.
World-Class Scientists,
World-Class Ventures
Our advisory team—authors of hundreds of papers in the world’s top journals—guides every venture with gold-standard evidence and global credibility.
Professor David Cameron- Smith
Scientific Advisor
Professor David Cameron-Smith is an international authority on human nutrition with 25 years’ experience spanning academia, clinical research and food-industry innovation. Former Science Director of New Zealand’s High-Value Nutrition programme and current Chair of Nutrition at the University of Auckland’s Liggins Institute, he leads landmark studies on diet-gene interactions, muscle metabolism and healthy ageing, advising governments and global FMCG on evidence-based product strategy.
Professor Catherine Stanton
Scientific Advisor
Professor Catherine Stanton is a leading microbiome and functional-foods scientist with more than 25 years at Teagasc Moorepark and an adjunct professorship at University College Cork. Author of 600+ papers and multiple patents, she bridges dairy science, probiotics and infant nutrition, guiding global companies on translating gut-microbiota discoveries into clinically validated consumer products.
Professor Andrew Pipingas
Scientific Advisor
Professor Andrew Pipingas is a cognitive neuroscientist renowned for translating nutritional biochemistry into measurable brain-health outcomes. With over two decades at Swinburne’s Centre for Human Psychopharmacology, he leads placebo-controlled trials on polyphenols, nutraceuticals and lifestyle interventions, guiding government and industry partners on evidence-based strategies that enhance cognition, mood and healthy brain ageing.
Professor Paul Ross
Corporate & Strategy Lead, Co-Founder
Professor Paul Ross is an internationally acclaimed microbiologist and Director of APC Microbiome Ireland. Over a 30-year career—spanning Teagasc and University College Cork—he has authored 600+ papers and secured >20 patents on bacteriocins, probiotics and phage therapy, helping global nutrition and pharma partners convert breakthrough microbiome science into validated immune- and metabolic-health solutions.
Selected Publications
Peer-reviewed work authored by our founders and advisory panel in the world’s leading journals.